About gadobutrol
Gadolinium-based MRI contrast agent
Used for
- Enhances MRI images of the brain, spine, blood vessels, and other body areas.
- Helps detect or assess abnormalities, including tumors and inflammation.
Usual adult dose
Usually 0.1 mmol/kg intravenously for MRI; dose depends on the examination.
Usual dose in children
Usually 0.1 mmol/kg intravenously for approved MRI examinations; use depends on age and indication.
Common side effects
- Headache
- Nausea
- Dizziness
- Injection-site reactions
Important warnings
- Rare severe allergic reactions can occur.
- Risk of nephrogenic systemic fibrosis is higher with severe kidney problems.
- Gadolinium can remain in the body; use only when medically necessary.
- Tell imaging staff about kidney disease or previous contrast reactions.
Pregnancy
Use during pregnancy only when imaging is essential and expected benefits outweigh potential risks.
Breastfeeding
Breastfeeding may generally continue after administration; discuss concerns with the imaging team.
Interactions
- Other gadolinium-based contrast agents may increase exposure if given close together.
- No important interactions with most medicines are expected.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.